Heather Rees insider trades
Open-market stock purchases and sales by Heather Rees, Chief Financial Officer at Atossa Therapeutics, Inc, from SEC Form 4 filings since Jun 27, 2024.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- ATOS Atossa Therapeutics, Inc: other filings, last May 15, 2025